The case-fatality rate of meningococcal disease in Catalonia, 1990–1997

References

• Apicella MA. Neisseria meningitidis. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and Practice of Infectious Diseases. 5th ed. Philadephia: Churchill Livingstone; 2000. p. 2228–41.
   Google Scholar
• Gold R. Neisseria meningitidis. In: Long SS, Pickering LK, Prober CG, eds. Principles and Practice of Pediatric Infectious Diseases. 2nd ed. New York: Churchill Livingstone; 2003. p. 748–56.
   Google Scholar
• Rosenstein NE, Perkins BA, Stephens DS, Popovic T, Hughes JM. Meningococcal disease. N Engl J Med 2001; 344: 1378–88.
   PubMed Web of Science ®Google Scholar
• Van Deuren M, Brandtzaez P, Van der Meer JWM. Update on meningococcal disease with emphasis on pathogenesis and clinical management. Clin Microbiol Rev 2000; 13: 144–66.
   Google Scholar
• Anonymous. The menigococcal disease in Galicia: season 199596. Bol Epidemiol Galicia 1996; 9: 1–4.
   Google Scholar
• De Mateo Ontañón. The meningococcal disease in Spain, 1990 1997. Change in the epidemiological pattern. Rev Española Salud Publ 2000; 74: 387–96.
   PubMedGoogle Scholar
• Selvin S. Epidemiologic analysis. Oxford: University Press; 2001. p. 145–60.
   Google Scholar
• Hubert B, Goulet V, Riou JY Surveillance of meningococcal disease in France, 1990–1997. Eurosurv 1997; 2: 78–9.
   Google Scholar
• Ragunathan L, Ramsay M, Borrow R, Guiver M, Gray S, Kaczmarski B. Clinical features, laboratory findings and management of meningococcal meningitis in England and Wales: report of a 1997 survey of meningococcal meningitis. J Infect 2000; 40: 47–79.
   Google Scholar
• Moura AS, Pablos-Mendez A, Layton M, Weiss D. Epidemiology of meningococcal disease, New York city, 1989–2000. Emerg Infect Dis 2003; 9: 355–61.
   PubMedGoogle Scholar
• Pastor P, Medley FB, Murphy TV. Meningococcal disease in Dallas County, Texas: results of a 6-y population-based study. Ped Infect Dis J 2000; 19: 324–8.
   Google Scholar
• Hasting L, Stuart J, Andrews N, Begg N. A retrospective survey of clusters of meningococcal disease in England and Wales, 1993 to 1995: estimated risks of further cases in household and educational settings. Comm Dis Report Rev 1997; 7: R195–200.
   Google Scholar
• Jensen ES, Schonheyder HC, Lind I, Berthelsen L, Norgard B, Sorensen HT. Neisseria meningitidis phenotypic markers and septicaemia, disease progress and case-fatality rate of meningococcal disease: a 20-y population-based historical follow-up study in a Danish county. J Med Microbiol 2003; 52: 173–9.
   PubMedGoogle Scholar
• Fourquet F, Hubert B. Les infections a meningocoque en France en 1995. Bull Epidémiol Hebdom 1997; num. special: 22–24.
   Google Scholar
• Jensen ES, Berthelsen L, Lind I, Fussing V, Sorensen HT, Schonheyder HC. Period prevalence and case-fatality rate associated with distinctive clone complexes of Neisseria meningitidis serogroups B and C. Europ J Clin Microbiol Infect Dis 2002; 21: 506–12.
   PubMedGoogle Scholar
• Nelson RS, Morin CA, Cartter ML, Mshar P, Hadler JL, Beckett G, et al. Meningococcal disease. New England, 1993–1998. MMWR 1999; 48:629–33.
   Google Scholar
• Schuchat A, Robinson K, Wenger JD, Harrison LH, Farley M, Reingold AL, et al. Bacterial meningitis in the United States in 1995. New Engl J Med 1997; 333: 970–6.
   Google Scholar
• Spanjaard L, Bol P, de Marie S, Zanen HC. Association of meningococcal serogroups with the course of disease in the Netherlands 1959–83. Bull WHO 1987; 65: 861–8.
   PubMedGoogle Scholar
• Barquet N, Domingo P, Cayla JA, Gonzalez J, Rodrigo C, Fernandez-Viladrich P, et al. Meningococcal disease in a large urban population (Barcelona, 1987–1992). Arch Int Med 1999; 159: 2329–39.
   Google Scholar
• Sorensen HT, Nielsen GL, Schonheyder HC, Steffensen FH, Hansen I, Sabroe S, et al. Outcome of pre-hospital antibiotic treatment of meningococcal disease. J Clin Epidemiol 1998; 51: 717–21.
   PubMedGoogle Scholar
• Norgard B, Sorensen HT, Jensen ES, Faber T, Schonheyder HC, Nielsen GL. Pre-hospital parenteral antibiotic treatment of meningococcal disease and case fatality: a Danish population-based cohort study. J Infect 2002; 45: 144–51.
   PubMed Web of Science ®Google Scholar
• Read RC, Camp NJ, di Giovine FS, Borrow R, Kaczmarski EB, Chaudhary AG, et al. An interleukin-1 genotype is associated with fatal outcome of meningococcal disease. J Infect Dis 2000; 182: 1557–60.
   PubMedGoogle Scholar
• Westendorp RGJ, Langermans JAM, Huizinga TWJ, Elouali AH, Verweig CL, Boomsma DI, Vanderbrouke JP. Genetic influence of cytokine production and fatal meningococcal disease. Lancet 1997; 349: 170–3.
   Google Scholar
• Riordan FA, Marzouk O, Thomson AP, Sills JA, Hart CA. Prospective validation of the Glasgow Meningococcal Septicaemia Prognostic Score. Comparison with other scoring methods. Eur J Ped 2002; 161: 531–7.
   Google Scholar
• Harding D, Baines PB, Brull D, Vassiliou V, Ellis I, Hart A, et al. Severity of meningococcal disease in children and the angiotensin-converting enzyme insertion deletion polymorphism. Am J Resp Crit Care Med 2002; 165: 1103–6.
   PubMed Web of Science ®Google Scholar
• Malley R, Huskins C, Kuppermann N. Multivariable predictive models for adverse outcome of invasive meningococcal disease in children. J Pediatr 1996; 129: 702–10.
   Google Scholar
• Pollard AJ, Brittto J, Nadel S, DeMunter C, Habiti P, Levin M. Emergence management of meningococcal disease. Arch Dis Child 1999; 80: 290–6.
   PubMed Web of Science ®Google Scholar
• Spanjaard L, Bol P, de Marie S, Zanen HC. Association of meningococcal serotype with the course of disease: serotypes 2a and 2b in the Netherlands, 1959–1981. J Infect Dis 1987; 155: 277–82.
   PubMed Web of Science ®Google Scholar
• Palmer SR, Corson J, Hall R, Payne S, Ludlow J, Deere B, et al. Meningococcal disease in Wales: clinical features, outcome and public health management. J Infect 1992; 25: 321–8.
   PubMed Web of Science ®Google Scholar
• Squires SG, Pelletier L, Mungai M, Tsang R, Collins F, Stottz J. Invasive meningococcal disease in Canada, 1 January 1997 to 31 December 1998. Can Commun Dis Rep 2000; 26–21: 177–82.
   Google Scholar
• Donalisio MR, Kemp B, Rocha MM, Ramalheira RM. CFR for meningococcal disease: study in the region of Campinas, SP, Brazil 1993 to 1998. Rev Saude Pub 2000; 34: 589–95.
   PubMedGoogle Scholar
• Scholten RJPM, Bijlmer HA, Valkenburg HA, Dankert J. Patient and strain characteristics in relation to the outcome of meningococcal disease: a multivariate analysis. Epidemiol Infect 1994; 112: 115–24.
   PubMedGoogle Scholar
• Rosenstein NE, Perkins BA, Stephens DS, Lefkowitz L, Cartter ML, Danila R, et al. The changing epidemiology of meningococcal disease in the United States, 1992–1996. J Infect Dis 1999; 18: 1894–901.
   Google Scholar
• Booy R, Habibi P, Nadel S, de Munter C, Britto J, Morrison A, Levin M. Meningococcal Research Group. Reduction in case fatality rate from meningococcal disease associated with improved healthcare delivery. Arch Dis Child 2001; 85: 386–90.
   Google Scholar
• Roznovsky L, Krizova P, Struncova V, Dostal V, Plisek S, Kasal E, et al. Administration of antibiotics before admission in patients with meningococcal disease. Cent Eur J Public Health 2003; 11: 14–8.
   PubMedGoogle Scholar
• El Bushra HE, Hassan NM, Al-Hamdan NA, Al-Jeffri MH, Turkistani AM, Al-Jumaily A, et al. Determinants of CFRs of meningococcal disease during outbreaks in Makkah, Saudi Arabic, 1987–97. Epidemiol Infect 2000; 125: 555–60.
   Google Scholar
• Erickson L, De Wals P. Complications and sequelae of meningococcal disease in Quebec, Canada, 1990–1994. Clin Infect Dis 1998; 26: 1159–64.
   PubMed Web of Science ®Google Scholar
• Ward J, Hanna JN, Bates JR, Selvey LA. Enhanced surveillance for meningococcal disease in Queensland in 1999. Commun Dis Intell 2000; 24: 332–5.
   PubMedGoogle Scholar
• Salleras L, Domínguez A, Prats G, Ramon I, Muñoz P. Dramatic decline of serogroup C meningococcal disease incidence in Catalonia (Spain) 24 months after a mass vaccination programme of children and young people. J Epidemiol Commun Health 2001; 55: 283–877.
   PubMed Web of Science ®Google Scholar
• Salleras L, Domínguez A, Cardeñosa N. Dramatic decline of serogroup C meningococcal disease in Catalonia (Spain) after a mass vaccination campaign with meningococcal C conjugated vaccine. Vaccine 2003; 21: 729–33.
   PubMed Web of Science ®Google Scholar
• Cartwright K, Morris R, Rümke H, Fox A, Borrow R, Begg N, et al. Immunogenicity and reactogenicity in UK infants of a novel meningococcal vesicle vaccine containing multiple class 1 (Por A) outer membrane proteins. Vaccine 1999; 17: 2612–9.
   Google Scholar
• Pizza M, Scarlato V, Masignani V, Giuliani MM, Arico B, Comanducci M, et al. Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing. Science 2000; 287: 1816–20.
   PubMed Web of Science ®Google Scholar
• Barroso DE, Carvalho DM, Netto MA, Santos OH, Nascimento FA, Werneck GL. The effect of subcapsular meningococcal B C vaccine on the prognosis of patients with meningococcal disease. Scand J Infect Dis 2002; 34: 417–20.
   PubMed Web of Science ®Google Scholar
• Claassen I, Meylis J, van der Ley P, Peeters C, Brons H, Robert J, et al. Production, characterization and control of a Neisseria meningitidis hexavalent class 1 outer membrane protein containing vesicle vaccine. Vaccine 1996; 14: 1001–8.
   Google Scholar
• De Kleijn E, van Eijndhoven L, Vermont C, Kuipers B, van Dijken H, Rumke H, et al. Serum bactericidal activity and isotype distribution of antibodies in toddlers and schoolchildren after vaccination with RIVM hexavalent PorA vesicle vaccine. Vaccine 2001; 20: 352–8.
   Google Scholar